Tissue microarrays in clinical urology : Technical considerationsKRAMER, Mario W; MERSEBURGER, Axel S; HENNENLOTTER, Jörg et al.Scandinavian journal of urology and nephrology. 2007, Vol 41, Num 6, pp 478-484, issn 0036-5599, 7 p.Article

The Commonly Performed Nerve Sparing Total Prostatectomy Does Not Acknowledge the Actual Nerve CoursesSIEVERT, Karl-Dietrich; HENNENLOTTER, Jörg; LAIBLE, Ines A et al.The Journal of urology. 2009, Vol 181, Num 3, pp 1076-1081, issn 0022-5347, 6 p.Article

Effective Treatment of Neurogenic Detrusor Dysfunction by Combined High-Dosed Antimuscarinics without Increased Side-EffectsAMEND, Bastian; HENNENLOTTER, Jörg; SCHDFER, Tobias et al.European urology. 2008, Vol 53, Num 5, pp 1021-1028, issn 0302-2838, 8 p.Article

The Prostate Cancer gene 3 assay: indications for use in clinical practiceSCHILLING, David; DE REIJKE, Theo; TOMBAL, Bertrand et al.BJU international (Papier). 2010, Vol 105, Num 4, pp 452-455, issn 1464-4096, 4 p.Article

Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomasDENGJEL, Jörn; NASTKE, Maria-Dorothea; HENNENLOTTER, Jorg et al.Clinical cancer research. 2006, Vol 12, Num 14, pp 4163-4170, issn 1078-0432, 8 p., 1Article

Preliminary Experience on the Use of the Adnatest^® System for Detection of Circulating Tumor Cells in Prostate Cancer PatientsTODENHÖFER, Tilman; HENNENLOTTER, Jorg; STENZL, Arnulf et al.Anticancer research. 2012, Vol 32, Num 8, pp 3507-3513, issn 0250-7005, 7 p.Article

Moderate degradation does not preclude microarray analysis of small amounts of RNASCHOOR, Oliver; WEINSCHENK, Toni; HENNENLOTTER, Jörg et al.BioTechniques. 2003, Vol 35, Num 6, pp 1192-1201, issn 0736-6205, 8 p.Article

Influence of Urinary Tract Instrumentation and Inflammation on the Performance of Urine Markers for the Detection of Bladder CancerTODENHOFER, Tilman; HENNENLOTTER, Jörg; KÜHS, Ursula et al.Urology (Ridgewood, NJ). 2012, Vol 79, Num 3, pp 620-624, issn 0090-4295, 5 p.Article

Activation of mTOR in renal cell carcinoma is due to increased phosphorylation rather than protein overexpressionKRUCK, Stephan; BEDKE, Jens; HENNENLOTTER, Jörg et al.Oncology reports. 2010, Vol 23, Num 1, pp 159-163, issn 1021-335X, 5 p.Article

Diagnostic value of MRI in a pelvic mass of prostatic originPHILIPP LICHY, Matthias; SCHLEMMER, Heinz-Peter; VOGEL, Ulrich et al.European urology. 2006, Vol 50, Num 6, pp 1357-1359, issn 0302-2838, 3 p.Article

Combined Application of Cytology and Molecular Urine Markers to Improve the Detection of Urothelial CarcinomaTODENHÖFER, Tilman; HENNENLOTTER, Jörg; ESSER, Michael et al.Cancer cytopathology. 2013, Vol 121, Num 5, pp 252-260, issn 1934-662X, 9 p.Article

Individual risk assessment in bladder cancer patients based on a multi-marker panelTODENHÖFER, Tilman; HENNENLOTTER, Jörg; AUFDERKLAMM, Stefan et al.Journal of cancer research and clinical oncology. 2013, Vol 139, Num 1, pp 49-56, issn 0171-5216, 8 p.Article

Influence of Renal Excretory Function on the Performance of Urine Based Markers to Detect Bladder CancerTODENHÖFER, Tilman; HENNENLOTTER, Jörg; WITSTRUK, Marc et al.The Journal of urology. 2012, Vol 187, Num 1, pp 68-73, issn 0022-5347, 6 p.Article

Follow-up of men with an elevated PCA3 score and a negative biopsy: does an elevated PCA3 score indeed predict the presence of prostate cancer?REMZI, Mesut; HAESE, Alexander; VAN POPPEL, Hein et al.BJU international (Papier). 2010, Vol 106, Num 8, pp 1138-1142, issn 1464-4096, 5 p.Article

Diagnostic value of MRI in a pelvic mass of prostatic origin: Part 2LICHY, Matthias Philipp; SCHLEMMER, Heinz-Peter; VOGEL, Ulrich et al.European urology. 2007, Vol 51, Num 1, pp 273-274, issn 0302-2838, 2 p.Article

Altered expression of Akt signaling pathway parameters in prostate needle biopsies derived from benign, adjacent and cancerous tissueWAALKES, Sandra; SIMON, Perikles; HENNENLOTTER, Jörg et al.Oncology reports. 2010, Vol 23, Num 5, pp 1257-1260, issn 1021-335X, 4 p.Article

Decreased expression of galectin-3 predicts tumour recurrence in pTa bladder cancerKRAMER, Mario Wolfgang; KUCZYK, Markus Antonius; HENNENLOTTER, Jörg et al.Oncology reports. 2008, Vol 20, Num 6, pp 1403-1408, issn 1021-335X, 6 p.Article

Loss of galectin-3 expression correlates with clear cell renal carcinoma progression and reduced survivalMERSEBURGER, Axel S; KRAMER, Mario W; HENNENLOTTER, Jörg et al.World journal of urology (Print). 2008, Vol 26, Num 6, pp 637-642, issn 0724-4983, 6 p.Article

A newly designed amplatz sheath decreases intrapelvic irrigation pressure during mini-percutaneous nephrolitholapaxy : An in-vitro pressure-measurement and microscopic studyNAGELE, Udo; HORSTMANN, Marcus; SIEVERT, Karl-Dietrich et al.Journal of endourology. 2007, Vol 21, Num 9, pp 1113-1116, issn 0892-7790, 4 p.Article

Promiscuous survivin peptide induces robust CD4+ T-cell responses in the majority of vaccinated cancer patientsWIDENMEYER, Melanie; GRIESEMANN, Heinrich; PASCOLO, Steve et al.International journal of cancer (Print). 2012, Vol 131, Num 1, pp 140-149, issn 0020-7136, 10 p.Article

Tumorsize dependent detection rate of endorectal MRI of prostate cancer—A histopathologic correlation with whole-mount sections in 70 patients with prostate cancerROETHKE, Matthias C; LICHY, Matthias P; JURGSCHAT, Leo et al.European journal of radiology. 2011, Vol 79, Num 2, pp 189-195, issn 0720-048X, 7 p.Article

Annexin A3 in Urine : A Highly Specific Noninvasive Marker for Prostate Cancer Early DetectionSCHOSTAK, Martin; SCHWALL, Gerhard P; KLOCKER, Helmut et al.The Journal of urology. 2009, Vol 181, Num 1, pp 343-353, issn 0022-5347, 11 p.Article

XPA-210: a new proliferation marker determines locally advanced prostate cancer and is a predictor of biochemical recurrenceAUFDERKLAMM, Stefan; HENNENLOTTER, Jörg; GERBER, Valentina et al.World journal of urology (Print). 2012, Vol 30, Num 4, pp 547-552, issn 0724-4983, 6 p.Article

Analysis of complex protein kinase B signalling pathways in human prostate cancer samplesJENDROSSEK, Verena; HENKEL, Marco; BELKA, Claus et al.BJU international (Papier). 2008, Vol 102, Num 3, pp 371-382, issn 1464-4096, 12 p.Article

HLA ligand profiles of primary renal cell carcinoma maintained in metastasesSTICKEL, Juliane Sarah; WEINZIERL, Andreas O; STEVANOVIC, Stefan et al.Cancer immunology and immunotherapy. 2009, Vol 58, Num 9, pp 1407-1417, issn 0340-7004, 11 p.Article